Read + Share
Amedeo Smart
Independent Medical Education
Yonehara R, Kumachi S, Kashiwagi K, Wakabayashi-Nakao K, et al. A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand. J Biol Chem 2023;299:102804.PMID: 36529290
Email
LinkedIn
Facebook
Twitter
Privacy Policy